Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
09:56:11 EDT Thu 19 Sep 2024
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

E:CYBN - CYBIN INC. - http://www.cybin.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CYBN - E  0.19.90·10.103.910.00-0.07-0.75.956219.50  10.10  9.500.98  0.2509:37:4909:2415 min RT 2¢
NEO exchange - E0.19.90·10.103.910.00-0.07-0.74.341149.50  10.10  9.500.98  0.2509:37:4915 min
Omega - O 9.90-0.17-1.71.51469.80  9.90  9.7009:35:1915 min
TriAct - M 0.265-9.805-97.40.111    15 min

Recent Trades - Last 10 of 21
Time ETExPriceChangeVolumeBuyerSellerMarkers
09:37:49E10.00-0.0710084 ITG8479 CIBCK
09:36:46E10.100.033001 Anonymous1 AnonymousK
09:35:19O9.90-0.171001 Anonymous1 AnonymousK
09:35:19O9.90-0.171001 Anonymous1 AnonymousK
09:35:13O9.90-0.171001 Anonymous1 AnonymousK
09:35:13O9.90-0.171001 Anonymous1 AnonymousK
09:35:08M9.80-0.2710084 ITG841 Anonymous
09:35:04E9.83-0.2450079 CIBC1 AnonymousK
09:35:04E9.83-0.2450079 CIBC1 AnonymousK
09:34:57E9.80-0.2740079 CIBC79 CIBCK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-09-19 09:24C:CYBN0.265News ReleaseCybin completes 1:38 share rollback
2024-09-17 18:05C:CYBN0.27RollbackCybin 1:38 rollback
2024-08-27 19:16C:CYBN0.345News ReleaseCybin shareholders OK matters at AGM
2024-08-13 16:15C:CYBN0.36News ReleaseCybin holds FDA initial breakthrough therapy meeting
2024-08-08 17:54C:CYBN0.365News ReleaseCybin has June 30 cash position of $183-million
2024-08-08 07:36C:CYBN0.365SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-08-08 07:36C:CYBN0.365SEDAR Interim MD & ASEDAR Interim MD & A
2024-08-07 07:30C:CYBN0.355News ReleaseCybin to Participate in the Canaccord Genuity 44th Annual Growth Conference
2024-06-26 15:29C:CYBN0.34News ReleaseCybin ends fiscal 2024 with cash of $209-million
2024-06-26 07:40C:CYBN0.36SEDAR MD & ASEDAR MD & A
2024-06-26 07:33C:CYBN0.36SEDAR Annual Information FormSEDAR Annual Information Form
2024-06-26 07:33C:CYBN0.36SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-06-19 07:30C:CYBN0.365News ReleaseCybin to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
2024-06-11 10:54C:CYBN0.385News ReleaseCybin appoints Mahableshwarkar SVP, clinic development
2024-05-30 14:26C:CYBN0.465News ReleaseNuminus to host Cybin trial on CYB003 at Cedar Clinical
2024-05-06 14:09C:CYBN0.485News ReleaseCybin reviews recent CYB003 activities
2024-04-18 13:00C:CYBN0.51News ReleaseCybin publishes CYB210010 research manuscript
2024-04-16 12:27C:CYBN0.51News ReleaseCybin receives depressive disorder therapy patent
2024-04-08 07:12C:CYBN0.55In the NewsGlobe says MindMed, Cybin get nod from U.S. FDA
2024-03-19 12:42C:CYBN0.61News ReleaseCybin closes $150-million (U.S.) private placement